GreenLight Biosciences Holdings, PBC financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
29 Hartwell Avenue, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Environmental Impact Acquisition Corp (to 2/3/2022)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % +33.4%
Debt-to-equity 205 % -22%
Return On Equity -374 % +49.2%
Return On Assets -123 % -42.8%
Operating Margin -1.5K % +81.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152M shares +23.5%
Common Stock, Shares, Outstanding 152M shares +23.3%
Entity Public Float 172M USD -10.9%
Common Stock, Value, Issued 15K USD +15.4%
Weighted Average Number of Shares Outstanding, Basic 152M shares +33.5%
Weighted Average Number of Shares Outstanding, Diluted 152M shares +33.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.3M USD +577%
General and Administrative Expense 35.1M USD +34.2%
Operating Income (Loss) -155M USD -25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.1M USD -27%
Income Tax Expense (Benefit) 1.09M USD
Net Income (Loss) Attributable to Parent -157M USD -21.7%
Earnings Per Share, Basic -1.12 USD/shares +44.1%
Earnings Per Share, Diluted -1.12 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.4M USD -61.1%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 37.7M USD -61.1%
Property, Plant and Equipment, Net 40.4M USD +76.8%
Operating Lease, Right-of-Use Asset 32.7M USD
Other Assets, Noncurrent 1.4M USD +8.95%
Assets 114M USD -7.14%
Accounts Payable, Current 1.07M USD -82.3%
Accrued Liabilities, Current 11.5M USD +22.1%
Liabilities, Current 31.2M USD +5.63%
Operating Lease, Liability, Noncurrent 48.7M USD
Other Liabilities, Noncurrent 991K USD -45.2%
Liabilities 91.8M USD +56.6%
Retained Earnings (Accumulated Deficit) -449M USD -53.9%
Stockholders' Equity Attributable to Parent 21.9M USD -65.6%
Liabilities and Equity 114M USD -7.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.1M USD +37.3%
Net Cash Provided by (Used in) Financing Activities -2.99M USD -103%
Net Cash Provided by (Used in) Investing Activities -1.61M USD -543%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 152M shares +23.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -35.7M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.8M USD -60.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 744K USD +20%
Deferred Tax Assets, Valuation Allowance 131M USD +76.6%
Deferred Tax Assets, Gross 141M USD +86.6%
Operating Lease, Liability 52.8M USD
Payments to Acquire Property, Plant, and Equipment 1.61M USD +460%
Lessee, Operating Lease, Liability, to be Paid 87.2M USD
Operating Lease, Liability, Current 4.08M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.28M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 9.57M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34.5M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.2M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.19M USD
Operating Lease, Payments 2.47M USD +21.1%
Additional Paid in Capital 471M USD +32.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.33M USD +11.4%
Deferred Tax Assets, Net of Valuation Allowance 9.64M USD +708%
Share-based Payment Arrangement, Expense 1.63M USD +301%
Interest Expense 1.01M USD -6.15%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%